Acessibilidade / Reportar erro

Persistent Chest Pain after COVID-19 Infection. Can Strain Echo Parameters Play a Role in Diagnosis and Prognostication?

COVID-19; Stress Echocardiographies; Myocarditis

Almost three years after the outbreak of the COVID-19 pandemic, the number of serious cases is decreasing with the large-scale implementation of the vaccine, but many long-term side effects are still affecting many patients who have previously contracted the virus.

In a 2021 meta-analysis,11. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Res Sq. 2021:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1. the five most common long-term effects of COVID-19 infection were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). Chest pain was present in 16% of the patients, and a similar prevalence was found in other studies.22. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5. doi: 10.1001/jama.2020.12603.

Although there are alternative non-cardiac causes for post-covid chest pain, like post-respiratory problems, musculoskeletal inflammatory syndrome,33. Khoja O, Passadouro BS, Mulvey M, Delis I, Astill S, Tan AL, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J Pain Res. 2022;15:1729-48. doi: 10.2147/JPR.S365026. or even previous pulmonary thromboembolism, persistent cardiac symptoms, including chest pain, palpitations and tachycardia may indicate underlying cardiac sequelae and deserve further investigation.

In the article by Özdemir et al.44. Özdemir E, Karagöz U, Emren SV, Altay S, Eren NK, Özdemir S, et al. Strain Echocardiographic Evaluation of Myocardial Involvement in Patients with Continuing Chest Pain after COVID-19 Infection. Arq Bras Cardiol. 2023; 120(1):e20220287. showed an association between strain echocardiographic (SE) parameters and cardiac magnetic resonanc (CMR) findings in patients with persistent chest pain after recovery from COVID-19 infection. Compared with the left ventricular ejection fraction (LVEF), the global longitudinal and circumferential strain had a stronger relationship with long-COVID-associated myocardial involvement, specifically previous myocarditis assessed by CMR.

Myocarditis during active covid infection is frequently sub-clinical and underdiagnosed, but its prevalence may be significant.55. Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, et al. COVID-19 and Myocarditis: A Systematic Review and Overview of Current Challenges. Heart Fail Rev. 2022;27(1):251-61. doi: 10.1007/s10741-021-10087-9. The long-term prognosis of myocarditis in this setting is still unknown, and further study is needed to determine whether COVID-19 myocarditis has similar outcomes compared with myocarditis from other causes.

In a study of a cohort of patients recently recovered from COVID-19 infection, CMR revealed cardiac involvement in 78 patients (78%) and ongoing myocardial inflammation in 60 patients (60%). This investigation found no association between the incidence of cardiac sequela and the severity of acute coronavirus illness and pre-existing conditions.66. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-73. doi: 10.1001/jamacardio.2020.3557.

An investigation of athletes who recovered from COVID-19 with CMR found evidence of myocardial inflammation in 46% of patients.77. Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021;6(1):116-8. doi: 10.1001/jamacardio.2020.4916.

While historically, endomyocardial biopsy has represented the diagnostic gold standard of acute myocarditis, over the last few years, CMR has emerged as the primary modality for diagnosis and risk stratification of myocarditis.

Furthermore, CMR is the gold standard for quantifying biventricular volumes and ejection fractions. CMR is recommended in patients with clinically suspected myocarditis or chest pain, normal coronaries, and raised troponin for the differential diagnosis of ischemic versus nonischemic origin.88. Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.

CMR diagnosis is often based on a clinical presentation consistent with myocarditis in conjunction with the presence of late gadolinium enhancement (LGE) in typical patterns and evidence of myocardial edema on T2 imaging. LGE detected by CMR reflects myocardial injury, i.e., necrosis and fibrosis.

Several CMR studies have shown LGE’s powerful diagnostic and prognostic value in myocarditis.99. Gräni C, Eichhorn C, Bière L, Murthy VL, Agarwal V, Kaneko K, et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017;70(16):1964-76. doi: 10.1016/j.jacc.2017.08.050.

In recent years, the measurement of left ventricular global and regional longitudinal strain (GLS) has been extensively studied to detect cardiac dysfunction in many cardiovascular disorders. Even subtle abnormalities of myocardial strain are powerful predictors of adverse events in numerous cardiovascular diseases, having an incremental value to ejection fraction and other traditional risk factors.1010. Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ. Global 2-Dimensional Strain as a New Prognosticator in Patients with Heart Failure. J Am Coll Cardiol. 2009;54(7):618-24. doi: 10.1016/j.jacc.2009.04.061.,1111. Stanton T, Leano R, Marwick TH. Prediction of All-Cause Mortality from Global Longitudinal Speckle Strain: Comparison with Ejection Fraction and Wall Motion Scoring. Circ Cardiovasc Imaging. 2009;2(5):356-64. doi: 10.1161/CIRCIMAGING.109.862334.

GLS reflects the longitudinal contraction of the myocardium. This method is more operator independent and more reproducible than EF.

In patients with acute myocarditis and preserved LVEF, a significant reduction of GLS compared to healthy subjects was detected. Further, regional longitudinal strain added important information to the localization and extent of myocardial injury. These findings were favorably compared with CMR’s quantification of late gadolinium enhancement.1212. Meindl C, Paulus M, Poschenrieder F, Zeman F, Maier LS, Debl K. Patients with Acute Myocarditis and Preserved Systolic Left Ventricular Function: Comparison of Global and Regional Longitudinal Strain Imaging by Echocardiography with Quantification of Late Gadolinium Enhancement by CMR. Clin Res Cardiol. 2021;110(11):1792-1800. doi: 10.1007/s00392-021-01885-0.

In COVID-19 myocarditis, baseline GLS, LVEF, and the extent of LGE in CMR were independent predictors of functional recovery in the follow-up.1313. D’Andrea A, Cante L, Palermi S, Carbone A, Ilardi F, Sabatella F, et al. COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden. Int J Environ Res Public Health. 2022;19(10):5898. doi: 10.3390/ijerph19105898.

The diagnostic confirmation of myocarditis, whether COVID-19 or non-COVID-19 related, will continue to rely on CMR and endomyocardial biopsy when indicated, but given the current evidence and since the accessibility of CMR is often limited, a more accessible method like 2D strain evaluation may play a role in screening and selecting patients for more extensive evaluation.

Referências

  • 1
    Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Res Sq. 2021:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1.
  • 2
    Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-5. doi: 10.1001/jama.2020.12603.
  • 3
    Khoja O, Passadouro BS, Mulvey M, Delis I, Astill S, Tan AL, et al. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J Pain Res. 2022;15:1729-48. doi: 10.2147/JPR.S365026.
  • 4
    Özdemir E, Karagöz U, Emren SV, Altay S, Eren NK, Özdemir S, et al. Strain Echocardiographic Evaluation of Myocardial Involvement in Patients with Continuing Chest Pain after COVID-19 Infection. Arq Bras Cardiol. 2023; 120(1):e20220287.
  • 5
    Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, et al. COVID-19 and Myocarditis: A Systematic Review and Overview of Current Challenges. Heart Fail Rev. 2022;27(1):251-61. doi: 10.1007/s10741-021-10087-9.
  • 6
    Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-73. doi: 10.1001/jamacardio.2020.3557.
  • 7
    Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021;6(1):116-8. doi: 10.1001/jamacardio.2020.4916.
  • 8
    Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document. Circ Heart Fail. 2020;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.
  • 9
    Gräni C, Eichhorn C, Bière L, Murthy VL, Agarwal V, Kaneko K, et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol. 2017;70(16):1964-76. doi: 10.1016/j.jacc.2017.08.050.
  • 10
    Cho GY, Marwick TH, Kim HS, Kim MK, Hong KS, Oh DJ. Global 2-Dimensional Strain as a New Prognosticator in Patients with Heart Failure. J Am Coll Cardiol. 2009;54(7):618-24. doi: 10.1016/j.jacc.2009.04.061.
  • 11
    Stanton T, Leano R, Marwick TH. Prediction of All-Cause Mortality from Global Longitudinal Speckle Strain: Comparison with Ejection Fraction and Wall Motion Scoring. Circ Cardiovasc Imaging. 2009;2(5):356-64. doi: 10.1161/CIRCIMAGING.109.862334.
  • 12
    Meindl C, Paulus M, Poschenrieder F, Zeman F, Maier LS, Debl K. Patients with Acute Myocarditis and Preserved Systolic Left Ventricular Function: Comparison of Global and Regional Longitudinal Strain Imaging by Echocardiography with Quantification of Late Gadolinium Enhancement by CMR. Clin Res Cardiol. 2021;110(11):1792-1800. doi: 10.1007/s00392-021-01885-0.
  • 13
    D’Andrea A, Cante L, Palermi S, Carbone A, Ilardi F, Sabatella F, et al. COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden. Int J Environ Res Public Health. 2022;19(10):5898. doi: 10.3390/ijerph19105898.
  • Short Editorial related to the article: Strain Echocardiographic Evaluation of Myocardial Involvement in Patients with Continuing Chest Pain after COVID-19 Infection

Publication Dates

  • Publication in this collection
    10 Feb 2023
  • Date of issue
    Jan 2023
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br